Publications

FDA’s Deceptive Drug Ad Focus Leaves Telehealth Sites Guessing

Quoted, Bloomberg Law

Associate Suzanne Bassett discusses the FDA's increasing scrutiny of telehealth companies utilizing social media influencers to promote boutique versions of popular drugs, highlighting the challenges this creates for these companies.